<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Management and Marketing - Journal Articles</title>
<link>http://hdl.handle.net/10468/213</link>
<description/>
<pubDate>Fri, 24 May 2013 10:26:33 GMT</pubDate>
<dc:date>2013-05-24T10:26:33Z</dc:date>
<item>
<title>Dance-work: Images of organization in Irish dance</title>
<link>http://hdl.handle.net/10468/209</link>
<description>Dance-work: Images of organization in Irish dance
Kavanagh, Donncha; Kuhling, Carmen; Keohane, Kieran
The Irish economic boom, commonly known as the Celtic Tiger, provides an interesting and unique opportunity to explore the relationship between the profound shifts in the organization of working life and in the production and consumption of culture. In this paper, we confine our inquiry into the relationship with one aspect of popular culture, namely dance, focusing on the phenomenon of Riverdance which emerged contemporaneously with the Celtic Tiger. We argue that both are deeply immersed in larger organizing discourses, historical narratives about national identity and civilizing attempts to control the body. We identify three distinct 'moments' in the development of Irish dance, which we label as pre-national, 'Traditional' Ireland; national, 'Modern', Parochial Ireland and global, 'Post-modern' Ireland. This provides a narrative through which we explore the transformation of working relations in Ireland during the 19th and 20th centuries.
</description>
<pubDate>Mon, 01 Sep 2008 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10468/209</guid>
<dc:date>2008-09-01T00:00:00Z</dc:date>
</item>
<item>
<title>International pricing and distribution of therapeutic pharmaceuticals – An ethical minefield</title>
<link>http://hdl.handle.net/10468/20</link>
<description>International pricing and distribution of therapeutic pharmaceuticals – An ethical minefield
Buckley, Joan; Ó Tuama, Séamus
This paper seeks to identify and consider ethical issues relating to the international pricing of pharmaceuticals, drawing especially on liberal rights theories. It suggests why and how some of these issues might be resolved. It examines and critiques arguments presented by major pharmaceutical manufacturers. It addresses a range of ancillary issues like current pricing policies, R&amp;D, intellectual property rights, rights to profits, the public good and regulation. It proposes a potential model for moving forward on the pricing of pharmaceuticals, with a view to increasing access to essential drugs.
</description>
<pubDate>Fri, 01 Apr 2005 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10468/20</guid>
<dc:date>2005-04-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
